# ELREXFIO
> **BLA761345** · Biologics License Application · Sponsor: PFIZER INC · Approved 2023-08-14
## Drug
- **FDA Application Number:** BLA761345
- **Application type:** Biologics License Application
- **Brand name:** ELREXFIO
- **Generic name:** ELRANATAMAB-BCMM
- **Active ingredients:** ELRANATAMAB
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** PFIZER INC
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2023-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761345)
---
*MORVS · CC0 1.0*